Avidity Biosciences Inc (RNA) Stock Analysis

Avidity Biosciences Inc (RNA) is a publicly traded company in the HEALTHCARE sector. It trades at $12.25, carries a market capitalization of $216.90M. This page summarizes the public market data, fundamentals, and frequently asked questions for RNA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Avidity Biosciences Inc currently has a Bullish sentiment score of 0.20.

About Avidity Biosciences Inc

Avidity Biosciences, Inc. (RNA) is a pioneering biopharmaceutical company based in La Jolla, California, focused on advancing innovative oligonucleotide-based therapies for the treatment of a range of serious diseases, including rare genetic disorders. Leveraging its proprietary Avidity platform, the company aims to create targeted RNA therapeutics that enhance the delivery and efficacy of therapeutic agents. With a robust pipeline of candidates in various stages of development, Avidity is po...

GNG Research Analysis

GNG Research scores Avidity Biosciences Inc (RNA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RNA.

Frequently Asked Questions

Does RNA pay dividends?

Avidity Biosciences Inc (RNA) does not currently pay a regular dividend.

What is RNA's market cap?

Avidity Biosciences Inc (RNA) has a market capitalization of $216.90M with a current stock price of $12.25.